|
1
|
Dufour X, Beby-Defaux A, Agius G and Lacau
St Guily J: HPV and head and neck cancer. Eur Ann Otorhinolaryngol
Head Neck Dis. 129:26–31. 2012. View Article : Google Scholar
|
|
2
|
Marur S and Forastiere AA: Head and neck
cancer: Changing epidemiology, diagnosis, and treatment. Mayo Clin
Proc. 83:489–501. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nguyen LV, Vanner R, Dirks P and Eaves CJ:
Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–143.
2012.PubMed/NCBI
|
|
4
|
Bertolini G, Roz L, Perego P, Tortoreto M,
Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S,
et al: Highly tumorigenic lung cancer CD133+ cells
display stem-like features and are spared by cisplatin treatment.
Proc Natl Acad Sci USA. 106:16281–16286. 2009. View Article : Google Scholar
|
|
5
|
Baumann M, Krause M and Hill R: Exploring
the role of cancer stem cells in radioresistance. Nat Rev Cancer.
8:545–554. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O’Brien CA, Kreso A and Jamieson CH:
Cancer stem cells and self-renewal. Clin Cancer Res. 16:3113–3120.
2010. View Article : Google Scholar
|
|
8
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
9
|
Chen YC, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shcherbata HR, Hatfield S, Ward EJ,
Reynolds S, Fischer KA and Ruohola-Baker H: The MicroRNA pathway
plays a regulatory role in stem cell division. Cell Cycle.
5:172–175. 2006. View Article : Google Scholar
|
|
12
|
Tamagawa S, Beder LB, Hotomi M, Gunduz M,
Yata K, Grenman R and Yamanaka N: Role of miR-200c/miR-141 in the
regulation of epithelial-mesenchymal transition and migration in
head and neck squamous cell carcinoma. Int J Mol Med. 33:879–886.
2014.PubMed/NCBI
|
|
13
|
DeSano JT and Xu L: MicroRNA regulation of
cancer stem cells and therapeutic implications. AAPS J. 11:682–692.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kozomara A and Griffiths-Jones S: miRBase:
Annotating high confidence microRNAs using deep sequencing data.
Nucleic Acids Res. 42(D1): D68–D73. 2014. View Article : Google Scholar :
|
|
15
|
Minn H, Clavo AC, Grénman R and Wahl RL:
In vitro comparison of cell proliferation kinetics and uptake of
tritiated fluorode-oxyglucose and L-methionine in squamous-cell
carcinoma of the head and neck. J Nucl Med. 36:252–258.
1995.PubMed/NCBI
|
|
16
|
Lansford CD, Grenman R, Bier H, Somers KD,
Kim S-Y, Whiteside TL, Clayman GL, Welkoborsky H-J and Carey TE:
Head and neck cancers. Human Cell Culture, Vol. 2, Cancer Cell
Lines Part 2. Masters JR and Palsson B: Norwell: Kluwer Academic
Publishers; pp. 185–255. 1999
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (−Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Pastrana E, Silva-Vargas V and Doetsch F:
Eyes wide open: A critical review of sphere-formation as an assay
for stem cells. Cell Stem Cell. 8:486–498. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Major AG, Pitty LP and Farah CS: Cancer
stem cell markers in head and neck squamous cell carcinoma. Stem
Cells Int. 2013:3194892013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen C, Wei Y, Hummel M, Hoffmann TK,
Gross M, Kaufmann AM and Albers AE: Evidence for
epithelial-mesenchymal transition in cancer stem cells of head and
neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mack B and Gires O: CD44s and CD44v6
expression in head and neck epithelia. PLoS One. 3:e33602008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Deng S, Yang X, Lassus H, Liang S, Kaur S,
Ye Q, Li C, Wang LP, Roby KF, Orsulic S, et al: Distinct expression
levels and patterns of stem cell marker, aldehyde dehydrogenase
isoform 1 (ALDH1), in human epithelial cancers. PLoS One.
5:e102772010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nam EJ, Lee M, Yim GW, Kim JH, Kim S, Kim
SW and Kim YT: MicroRNA profiling of a CD133 (+) spheroid-forming
subpopulation of the OVCAR3 human ovarian cancer cell line. BMC Med
Genomics. 5:182012. View Article : Google Scholar
|
|
24
|
Sun JG, Liao RX, Qiu J, Jin JY, Wang XX,
Duan YZ, Chen FL, Hao P, Xie QC, Wang ZX, et al: Microarray-based
analysis of microRNA expression in breast cancer stem cells. J Exp
Clin Cancer Res. 29:1742010. View Article : Google Scholar
|
|
25
|
Huang CX, Zhu Y, Duan GL, Yao JF, Li ZY,
Li D and Wang QQ: Screening for MiRNAs related to laryngeal
squamous carcinoma stem cell radiation. Asian Pac J Cancer Prev.
14:4533–4537. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oneyama C, Kito Y, Asai R, Ikeda J,
Yoshida T, Okuzaki D, Kokuda R, Kakumoto K, Takayama K, Inoue S, et
al: MiR-424/503-mediated Rictor upregulation promotes tumor
progression. PLoS One. 8:e803002013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F,
Xie X, Zhou C and Lu W: Suppressed miR-424 expression via
upregulation of target gene Chk1 contributes to the progression of
cervical cancer. Oncogene. 32:976–987. 2013. View Article : Google Scholar
|
|
28
|
Cheung TH, Man KN, Yu MY, Yim SF, Siu NS,
Lo KW, Doran G, Wong RR, Wang VW, Smith DI, et al: Dysregulated
microRNAs in the pathogenesis and progression of cervical neoplasm.
Cell Cycle. 11:2876–2884. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pouliot LM, Chen YC, Bai J, Guha R, Martin
SE, Gottesman MM and Hall MD: Cisplatin sensitivity mediated by
WEE1 and CHK1 is mediated by miR-155 and the miR-15 family. Cancer
Res. 72:5945–5955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Li T, Guo P, Kang J, Wei Q, Jia
X, Zhao W, Huai W, Qiu Y, Sun L, et al: MiR-424-5p reversed
epithelial-mesenchymal transition of anchorage-independent HCC
cells by directly targeting ICAT and suppressed HCC progression.
Sci Rep. 4:62482014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu CC, Chen YW, Chiou GY, Tsai LL, Huang
PI, Chang CY, Tseng LM, Chiou SH, Yen SH, Chou MY, et al: MicroRNA
let-7a represses chemoresistance and tumourigenicity in head and
neck cancer via stem-like properties ablation. Oral Oncol.
47:202–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni
L, Zhang WG, Nan KJ, Song TS and Huang C: MicroRNA profiling of
human gastric cancer. Mol Med Rep. 2:963–970. 2009.PubMed/NCBI
|
|
33
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gaedcke J, Grade M, Camps J, Søkilde R,
Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi
BM, Møller S, et al: The rectal cancer microRNAome - microRNA
expression in rectal cancer and matched normal mucosa. Clin Cancer
Res. 18:4919–4930. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ranade AR, Cherba D, Sridhar S, Richardson
P, Webb C, Paripati A, Bowles B and Weiss GJ: MicroRNA
92a-2*: A biomarker predictive for chemoresistance and
prognostic for survival in patients with small cell lung cancer. J
Thorac Oncol. 5:1273–1278. 2010. View Article : Google Scholar : PubMed/NCBI
|
